One study showed an increased percentage of inflammatory monocytes expressing S100A8+ S100A9 (calprotectin), CD14 and CD62L, possibly correlating with a profibrotic differentiation pattern in severe COVID-19 as compared to mild disease (42). The gene discussed is SELL; the disease is COVID-19.